Science Current Events | Science News | Brightsurf.com
 

New compound holds promise for treating Duchenne MD, other inherited diseases

June 28, 2012
RTC 13 effectively counteracts 'nonsense' mutation that causes disorder

Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.

Duchenne muscular dystrophy, or DMD, is a degenerative muscle disease that affects boys almost exclusively. It involves the progressive degeneration of voluntary and cardiac muscles, severely limiting the life span of sufferers.

In a new study, senior author Carmen Bertoni, an assistant professor in the UCLA Department of Neurology, first author Refik Kayali, a postgraduate fellow in Bertoni's lab, and their colleagues demonstrate the efficacy of a new compound known as RTC13, which suppresses so-called "nonsense" mutations in a mouse model of DMD.

The findings appear in the current online edition of the journal Human Molecular Genetics.

"We are excited about these new findings because they represent a major step toward the development of a drug that could potentially treat this devastating disease in humans," Bertoni said. "We knew that the compounds were effective in cells isolated from the mouse model for DMD, but we did not know how they would behave when administered in a living organism."

Nonsense mutations are generally caused by a single change in DNA that disrupts the normal cascade of events that changes a gene into messenger RNA, then into a protein. The result is a non-functioning protein. Approximately 13 percent of genetic defects known to cause diseases are due to such mutations. In the case of DMD, the "missing" protein is called dystrophin.

For the study, Bertoni and Kayali collaborated with the laboratory of Dr. Richard Gatti, a professor of pathology and laboratory medicine and of human genetics at UCLA. Working with the UCLA Molecular Shared Screening Resource facility at the campus's California NanoSystems Institute, the Gatti lab screened some 35,000 small molecules in the search for new compounds that could ignore nonsense mutations. Two were identified as promising candidates: RTC13 and RTC14.

The Bertoni lab tested RTC13 and RTC14 in a mouse model of DMD carrying a nonsense mutation in the dystrophin gene. While RTC14 was not found to be effective, RTC13 was able to restore significant amounts of dystrophin protein, making the compound a promising drug candidate for DMD. When RTC13 was administered to mice for five weeks, the investigators found that the compound partially restored full-length dystrophin, which resulted in a significant improvement in muscle strength. The loss of muscle strength is a hallmark of DMD.

The researchers also compared the level of dystrophin achieved to the levels seen with another experimental compound, PTC124, which has proved disappointing in clinical trials; RTC13 was found to be more effective in promoting dystrophin expression. Just as important, Bertoni noted, the study found that RTC13 was well tolerated in animals, which suggests it may also be safe to use in humans.

The next step in the research is to test whether an oral formulation of the compound would be effective in achieving therapeutically relevant amounts of dystrophin protein. If so, planning can then begin for clinical testing in patients and for expanding these studies to other diseases that may benefit from this new drug.

University of California - Los Angeles


Related Dystrophin Current Events and Dystrophin News Articles


Cardiac stem cell therapy may heal heart damage caused by Duchenne muscular dystrophy
Researchers at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells might help reverse heart damage caused by Duchenne muscular dystrophy, potentially resulting in a longer life expectancy for patients with the chronic muscle-wasting disease.

Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy
Scientists at USC have developed a new microscopy technology that allows them to view single molecules in living animals at higher-than-ever resolution.

Muscular dystrophy: Repair the muscles, not the genetic defect
A potential way to treat muscular dystrophy directly targets muscle repair instead of the underlying genetic defect that usually leads to the disease.

Discovery of new form of dystrophin protein could lead to therapy for some DMD patients
Scientists have discovered a new form of dystrophin, a protein critical to normal muscle function, and identified the genetic mechanism responsible for its production.

Cedars-Sinai study: Common drug restores blood flow in deadly form of muscular dystrophy
Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy.

Researchers identify way to increase gene therapy success
Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload.

New Muscular Dystrophy Treatment Shows Promise in Early Study Led by Children's National
A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD).

New muscular dystrophy treatment shows promise in early study
A preclinical study led by researchers in the United States has found that a new oral drug shows early promise for the treatment of muscular dystrophy.

New drug improves walking performance for Duchenne muscular dystrophy patients
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production of a protein vital to muscle growth and health.

Burnt sugar derivative reduces muscle wasting in fly and mouse muscular dystrophy
A trace substance in caramelized sugar, when purified and given in appropriate doses, improves muscle regeneration in a mouse model of Duchenne muscular dystrophy. The findings are published today, Aug. 1, in the journal Skeletal Muscle.
More Dystrophin Current Events and Dystrophin News Articles

The dystrophin protein family: Localization and physiological role

The dystrophin protein family: Localization and physiological role
by Diana Hazai (Author)


Duchenne muscular dystrophy (DMD)is one of the most common, severe human disease. Mutations in the DMD gene are responsible for the disorder. Due to the mutations, dystrophin proteins are not expressed or expressed in functionally impaired form. The dystrophins are members of the dystrophin-associated protein complex (DAPC)located in the sarcolemma in the striated muscle. The DAPC links the extracellular matrix to the actin-based cytoskeleton and anchors signalling molecules. DAPC proteins are also localized in neurons and glia cells within the central nervous system and they interact with each other building up different types of DAPCs. Finding out the localization, colocalization of the DAPC proteins and the construction of the DAPC within the brain was the aim of the...

Dystrophin: Gene, Protein and Cell Biology (French Edition)

Dystrophin: Gene, Protein and Cell Biology (French Edition)
by Susan C. Brown (Editor), Jack A. Lucy (Editor), Marlin Bobrow (Editor)


This book is concerned with advances in research on dystrophin, and how its absence gives rise to muscular dystrophy. It is the first book to address relationships between the molecular structure and function of dystrophin since the structure of the gene for this protein was elucidated in 1988. The volume covers recent advances in knowledge on the structure of both the dystrophin gene and its associated promoters, and on the protein itself. Functional interactions of dystrophin and its related proteins in the environment of the plasma membrane are a central feature of the book. Other aspects considered are the expression of the dystrophin complex in muscle, in the brain, and at the neuromuscular junction. The book concludes with discussions of muscle regeneration, gene therapy of Duchenne...

Dystrophin: Webster's Timeline History, 1806 - 2007

Dystrophin: Webster's Timeline History, 1806 - 2007
by Icon Group International (Author)


Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Dystrophin," including when used in literature (e.g. all authors that might have Dystrophin in their name). As such, this book represents the largest compilation of timeline events associated with Dystrophin when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences...

The dystrophin protein family: Localization and physiological role by Hazai, Diana published by LAP LAMBERT Academic Publishing (2010) [Paperback]

The dystrophin protein family: Localization and physiological role by Hazai, Diana published by LAP LAMBERT Academic Publishing (2010) [Paperback]
by LAP LAMBERT Academic Publishing (Publisher)




Biochemical Characterization of Dystrophin Spectrin Type Repeats: Biochemical and Biophysical analysis of Dystrophin Spectrin Type Repeats with emphasis on structure  prediction.

Biochemical Characterization of Dystrophin Spectrin Type Repeats: Biochemical and Biophysical analysis of Dystrophin Spectrin Type Repeats with emphasis on structure prediction.
by Ismaeel Muhamed (Author)


The dystrophin gene and its association with dystrophies is a prime factor to study the spectrin type repeats (STR) of dystrophin. There are 24 triple helical rods of Dystrophin STRs having four flexible hinges. The exon skipping and tissue specifity of the dystrophin isoforms make its function diverse. The deletion of STRs and mutations causes instability of the protein leading to diseases. This work studies the stability of spectrin type repeat, which would identify the roles and probably understand the function of individual spectrin repeat in diseases. The repeats are subjected to urea and temperature and the helical stability is measured. Structure prediction methods were worked on d1617 dystrophin spectrin double repeat to predict its structure which resulted in 4...

Structure and function of Native and edited dystrophin rods.

Structure and function of Native and edited dystrophin rods.
by ping (author) yu (Author)


Book by Sahni, Neha

Neuromuscular Disorders: Management and Treatment

Neuromuscular Disorders: Management and Treatment
by Saunders


Neuromuscular Disorders presents a multi-disciplinary approach to the management and therapeutic treatment of the full range of neuromuscular disorders and resulting complications. Dr. Tulio Bertorini and a contributing team of the world’s leading authorities in the field provide the latest tools and strategies for minimizing disability and maximizing quality of life.Effectively treat your patients using the latest management tools and targeted therapeutic strategies. Manage all neuromuscular disorders as well as resulting complications through comprehensive coverage of diagnosis and evaluations, treatments, and outcomes. Apply the multi-disciplinary approach of an expert in clinical neuromuscular care and a team of world-renown contributors. Easily refer to tools for diagnosis,...

Muscle Biopsy: A Practical Approach

Muscle Biopsy: A Practical Approach
by Saunders


Muscle Biopsy: A Practical Approach gives you all of the unparalleled guidance necessary to effectively interpret and diagnose muscle biopsy specimens for the full range of diseases in both adults and children. Authored by Dr. Victor Dubowitz, an internationally renowned figure in the field of muscle disease, this medical reference book takes an integrated approach to diagnosis and assessment of muscle biopsies that includes clinical, genetic, biochemical, and pathological features. It's the comprehensive, up-to-date coverage you need to evaluate muscle disorders with confidence.Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability.Bridge the gap between clinical syndromes/disorders and their underlying pathologies with the...

Thompson & Thompson Genetics in Medicine: With STUDENT CONSULT Online Access, 7e (Thompson and Thompson Genetics in Medicine)

Thompson & Thompson Genetics in Medicine: With STUDENT CONSULT Online Access, 7e (Thompson and Thompson Genetics in Medicine)
by Robert Nussbaum MD (Author), Roderick R. McInnes MD PhD FRS(C) (Author), Huntington F Willard PhD (Author)


Through six editions, Thompson & Thompson's Genetics in Medicine has been a well-established favorite textbook on this fascinating and rapidly evolving field, integrating the classic principles of human genetics with modern molecular genetics to help you understand a wide range of genetic disorders. The 7th edition incorporates the latest advances in molecular diagnostics, the Human Genome Project, and much more. More than 240 dynamic illustrations and high-quality photos help you grasp complex concepts more easily. In addition to the book, you will also receive STUDENT CONSULT, enabling you to access the complete contents of the book online, anywhere you go!Acquire the state-of-the-art knowledge you need on the latest advances in molecular diagnostics, the Human Genome Project,...

Physical Medicine and Rehabilitation Q&A Review

Physical Medicine and Rehabilitation Q&A Review
by Lyn D. Weiss MD (Editor), Harry J. Lenaburg MD (Editor), Jay M. Weiss MD (Editor)


Physical Medicine and Rehabilitation Q&A Review is a comprehensive active self-assessment tool for medical students, residents, and junior attending physicians in physical medicine and rehabilitation. The first question-and-answer review book in this field, it will help professionals quickly and efficiently review specific topics in PM&R. The book covers in detail the entire field of physical medicine and rehabilitation with more than 1,500 multiple-choice questions with answers and detailed rationales. Broken into 15 topic areas, Physical Medicine and Rehabilitation Q&A Review highlights all of the key concepts in the PM&R curriculum for learning and individual self-assessment. Designed to test recall and sharpen skills, the book addresses the fundamental components of PM&R training and...

© 2014 BrightSurf.com